Skip to main content

Understanding Type 2 Diabetes Medications Study Guide

This guide provides a comprehensive overview of the pharmacological approaches to managing Type 2 Diabetes Mellitus and its associated weight management challenges. It details various drug classes, including Biguanides, Thiazolidinediones, Alpha-Glucosidase Inhibitors, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Insulin Secretagogues. The guide also covers specific pharmacological agents for weight management, discussing their mechanisms of action, efficacy in glycemic contr

Save this study guide to your study set

Sign up free

Your learning path

Pathophysiology and Pharmacotherapy of Type 2 Diabetes

Pathophysiology and Management of Type 2 Diabetes

This content covers the pathophysiology of Type 2 Diabetes Mellitus, risk factors, goals of therapy, and medications used in managing Type 2 Diabetes.

  • Type 2 Diabetes Mellitus pathophysiology
  • Insulin resistance
  • Insulin homeostasis
  • Risk factors for Type 2 Diabetes
  • Microvascular and macrovascular complications
  • Biguanides (Metformin)
  • Incretins (GLP-1 and GIP)
  • Dipeptidyl-peptidase 4 inhibitors (DPP4-i)
  • Sitagliptin
  • Linagliptin

GLP-1 Receptor Agonists and Incretin Mimetics

Information regarding Glucagon-Like Peptide-1 Receptor Agonists and dual acting Glucose-Dependant Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Receptor Agonists including mechanism of action, product availability, and side effects.

  • Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA)
  • Mechanism of Action (MOA)
  • Liraglutide
  • Semaglutide
  • Tirzepatide
  • Incretin Mimetics
  • Glucose-Dependant Insulinotropic Polypeptide (GIP)
  • Subcutaneous Injection
  • Hypoglycemia risk
  • Weight loss promotion

Introduction to SGLT and SGLT2 Inhibitors

Sodium-Glucose Cotransporter-2 Inhibitors Overview

Sodium-Glucose Cotransporter-2 inhibitors (SGLT2i) stop reabsorption of glucose in urine to treat Type 2 Diabetes and Heart Failure.

  • Sodium Glucose co-transporters (SGLT)
  • SGLT-2
  • Sodium-Glucose Cotransport-2 inhibitors (SGLT-2i)
  • Empagliflozin
  • Dapagliflozin
  • Mechanism of Action
  • Hypoglycemia
  • Hypotension
  • Yeast Infections

Pharmacological Management of Type 2 Diabetes

Pharmacological Management of Type 2 Diabetes

This content details drug classes, mechanisms of action, side effects, and product availability for treating Type 2 diabetes and its sequelae.

  • Insulin Secretagogues
  • Sulfonylureas
  • Meglitinides
  • Thiazolidinediones
  • Alpha-glucosidase inhibitors
  • Biguanides
  • GLP-1 receptor agonists
  • DPP-4 inhibitors
  • Insulin regimens
  • Combination products

Type 2 Diabetes and Weight Management

Medications used in managing Type 2 Diabetes, weight management, and managing sequelae of diabetes.

  • Orlistat mechanism of action
  • Bupropion and Naltrexone combination
  • GLP1 Receptor agonists
  • Biguanides
  • Dipeptidyl-peptidase 4 inhibitors
  • Incretin Mimetics
  • Sodium Glucose Cotransporter-2 Inhibitors
  • Insulin Secretagogues
  • Thiazolidinediones
  • Alpha-Glucosidase inhibitor
  • Cardiovascular and Renal protection
  • Hypoglycemia management

Make it your own.

Keep these readings and topics in a new study set, or add them to one you already use.